The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Alterations of Phospholamban Function Can Exhibit Cardiotoxic Effects Independent of Excessive Sarcoplasmic Reticulum Ca 2+ -ATPase Inhibition
Abstract
Background— Low activity of the sarco(endo)plasmic reticulum Ca 2+ -ATPase (SERCA2a) resulting from strong inhibition by phospholamban (PLN) can depress cardiac contractility and lead to dilated cardiomyopathy and heart failure. Here, we investigated whether PLN exhibits cardiotoxic effects via mechanisms other than chronic inhibition of SERCA2a by studying a PLN mutant, PLN R9C , that triggers cardiac failure in humans and mice. Methods and Results— Because PLN R9C inhibits SERCA2a mainly by preventing deactivation of wild-type PLN, SERCA2a activity could be increased stepwise by generating mice that carry a PLN R9C transgene and 2, 1, or 0 endogenous PLN alleles (PLN +/+ +TgPLN R9C , PLN +/− +TgPLN R9C , and PLN −/− +TgPLN R9C , respectively). PLN −/− +TgPLN R9C hearts demonstrated accelerated sarcoplasmic reticulum Ca 2+ uptake rates and improved hemodynamics compared with PLN +/+ +TgPLN R9C mice but still responded poorly to β-adrenergic stimulation because PLN R9C impairs protein kinase A–mediated phosphorylation of both wild-type and mutant PLN. PLN +/+ +TgPLN R9C mice died of heart failure at 21±6 weeks, whereas heterozygous PLN +/− +TgPLN R9C mice survived to 48±11 weeks, PLN −/− +TgPLN R9C mice to 66±19 weeks, and wild-type mice to 94±27 weeks ( P <0.001). Although Ca 2+ reuptake kinetics in young PLN −/− +TgPLN R9C mice exceeded those measured in wild-type control animals, this parameter alone was not sufficient to prevent the eventual development of dilated cardiomyopathy. Conclusions— The data demonstrate an association between the dose-dependent inhibition of SERCA2a activity by PLN wt and the time of onset of heart failure and show that a weak inhibitor of SERCA2a, PLN R9C , which is diminished in its ability to modify the level of SERCA2a activity, leads to heart failure despite fast sarcoplasmic reticulum Ca 2+ reuptake.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Although several X-ray crystallography and cryo-electron microscopy studies focused on SERCA have revealed important details on calcium translocation,5–9 structural data on the SERCA/PLN complex10–13 are sparse and do not offer mechanistic details on the regulatory function of PLN.”
From Lipid-Mediated Folding/Unfolding of Phospholamban as a Regulatory Mechanism for the Sarcoplasmic Reticulum Ca2+-ATPase (2011) · cites this paper as [13]
In the citing paper
“we did not detect any phosphorylation for pentameric PLNR9C under either reducing or oxidizing conditions (Fig. 1B).”
From Lethal Arg9Cys phospholamban mutation hinders Ca 2+ -ATPase regulation and phosphorylation by protein kinase A (2011) · cites this paper as [24]
In the citing paper
“R9C cardiotoxic effects are correlated with inefficient Ca2+ handling (23) and show a dose-dependent inhibition of SERCA (24).”
From Lethal Arg9Cys phospholamban mutation hinders Ca 2+ -ATPase regulation and phosphorylation by protein kinase A (2011) · cites this paper as [24]
In the citing paper
“This is consistent with the observed R9C phenotypes for both heterozygous mice (24) and human patients (22).”
From Lethal Arg9Cys phospholamban mutation hinders Ca 2+ -ATPase regulation and phosphorylation by protein kinase A (2011) · cites this paper as [24]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Phospholamban: a crucial regulator of cardiac contractility
MacLennan, D. H., & Kranias, E. G. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1151 · Cited by 1,088
Self-citationThe enhanced contractility of the phospholamban-deficient mouse heart persists with aging
Slack, J. P., Grupp, I. L., Dash, R., Holder, D., Schmidt, A., Gerst, M. J., Tamura, T., Tilgmann, C., James, P. F., Johnson, R., et al. (2001) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.2001.1370 · Cited by 64
Research works printed but not linked: 20
- 10.1016/S0092-8674(01)00242-2 · DOI · Paper page
- 10.1073/pnas.0606383103 · DOI
- 10.1074/mcp.M700245-MCP200 · DOI
- 10.1126/science.1081578 · DOI · Paper page
- 10.1152/ajpcell.1990.258.2.C318 · doi:10.1152/ajpcell.1990.258.2.c318
- 10.1074/jbc.273.8.4734 · DOI
- 10.1006/jmcc.2002.2037 · DOI · Paper page
- 10.1172/JCI118446 · DOI · Paper page
- 10.1161/res.75.3.8062415 · doi:10.1161/res.75.3.8062415
- 10.1016/S0092-8674(00)81662-1 · DOI · Paper page
- 10.1074/jbc.M006889200 · DOI
- 10.1172/JCI17892 · DOI · Paper page
- 10.1161/res.88.4.383 · doi:10.1161/res.88.4.383
- 10.1172/JCI11093 · DOI · Paper page
- 10.1016/S0021-9258(17)42051-5 · DOI · Paper page
- 10.1161/circulationaha.105.583351 · DOI
- 10.1161/01.cir.0000117254.68497.39 · DOI
- 10.1038/79592 · doi:10.1038/79592
- 10.1172/JCI200316738 · DOI
- 10.1172/JCI18716 · DOI · Paper page
Cited by
Ha, K. N., Masterson, L. R., Hou, Z., Verardi, R., Walsh, N., Veglia, G., & Robia, S. L. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1013987108 · Cited by 91
Gustavsson, M., Traaseth, N. J., Karim, C. B., Lockamy, E. L., Thomas, D. D., & Veglia, G. (2011) · Journal of Molecular Biology · doi:10.1016/j.jmb.2011.03.015 · Cited by 63
Metadata
- Authors
- Schmitt, J. P., Ahmad, F., Lorenz, K., Hein, L., Schulz, S., Asahi, M., MacLennan, D. H., Seidman, C. E., Seidman, J. G., & Lohse, M. J.
- Affiliations
- From the Institute of Pharmacology and Toxicology, University of Würzburg, Würzburg, Germany (J.P.S., K.L., L.H., M.J.L.); Cardiovascular Institute, University of Pittsburgh, Pittsburgh, Pa (F.A.); Institute of Pharmacology and Toxicology, University of Freiburg, Freiburg, Germany (L.H.); Institute of Pharmacology and Toxicology, University of Jena, Jena, Germany (S.S.); Banting and Best Department of Medical Research, University of Toronto, Toronto, Ontario, Canada (M.A., D.H.M.); Cardiovascular...
- Venue
- Circulation
- Published
- 2009-01-27
- Volume
- 119
- Issue
- 3
- Pages
- 436-444
- ISSN
- 0009-7322
- 1524-4539
- Cited by
- 47
- References
- 2
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Alterations of Phospholamban Function Can Exhibit Cardiotoxic Effects Independent of Excessive Sarcoplasmic Reticulum Ca 2+ -ATPase Inhibition. https://app.cochat.ai/papers/10.1161/circulationaha.108.783506
- The paper
- Schmitt, J. P., Ahmad, F., Lorenz, K., Hein, L., Schulz, S., Asahi, M., MacLennan, D. H., Seidman, C. E., Seidman, J. G., & Lohse, M. J. (2009). Alterations of Phospholamban Function Can Exhibit Cardiotoxic Effects Independent of Excessive Sarcoplasmic Reticulum Ca 2+ -ATPase Inhibition. Circulation. https://doi.org/10.1161/circulationaha.108.783506
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.